nodes	percent_of_prediction	percent_of_DWPC	metapath
Eprosartan—ABCC2—Vincristine—muscle cancer	0.265	0.318	CbGbCtD
Eprosartan—ABCC2—Etoposide—muscle cancer	0.243	0.291	CbGbCtD
Eprosartan—ABCC2—Doxorubicin—muscle cancer	0.166	0.199	CbGbCtD
Eprosartan—ABCC2—Methotrexate—muscle cancer	0.161	0.192	CbGbCtD
Eprosartan—Neuropathy peripheral—Vincristine—muscle cancer	0.00103	0.00622	CcSEcCtD
Eprosartan—Otitis media—Doxorubicin—muscle cancer	0.00101	0.00612	CcSEcCtD
Eprosartan—Gingivitis—Doxorubicin—muscle cancer	0.00101	0.00607	CcSEcCtD
Eprosartan—Herpes simplex—Methotrexate—muscle cancer	0.000989	0.00597	CcSEcCtD
Eprosartan—Alanine aminotransferase increased—Etoposide—muscle cancer	0.000974	0.00588	CcSEcCtD
Eprosartan—Glycosuria—Doxorubicin—muscle cancer	0.000974	0.00588	CcSEcCtD
Eprosartan—Rigors—Doxorubicin—muscle cancer	0.000966	0.00583	CcSEcCtD
Eprosartan—Chills—Dactinomycin—muscle cancer	0.000947	0.00572	CcSEcCtD
Eprosartan—Sweating increased—Etoposide—muscle cancer	0.000929	0.00561	CcSEcCtD
Eprosartan—Cystitis noninfective—Methotrexate—muscle cancer	0.00089	0.00537	CcSEcCtD
Eprosartan—Cystitis—Methotrexate—muscle cancer	0.00088	0.00531	CcSEcCtD
Eprosartan—Viral infection—Doxorubicin—muscle cancer	0.000873	0.00527	CcSEcCtD
Eprosartan—Arthropathy—Doxorubicin—muscle cancer	0.000867	0.00524	CcSEcCtD
Eprosartan—Herpes simplex—Doxorubicin—muscle cancer	0.000856	0.00517	CcSEcCtD
Eprosartan—Ill-defined disorder—Dactinomycin—muscle cancer	0.000852	0.00515	CcSEcCtD
Eprosartan—Renal failure—Etoposide—muscle cancer	0.000836	0.00505	CcSEcCtD
Eprosartan—Neuropathy peripheral—Etoposide—muscle cancer	0.000834	0.00504	CcSEcCtD
Eprosartan—Malaise—Dactinomycin—muscle cancer	0.000828	0.005	CcSEcCtD
Eprosartan—Bladder pain—Methotrexate—muscle cancer	0.000824	0.00497	CcSEcCtD
Eprosartan—Urine output increased—Methotrexate—muscle cancer	0.000824	0.00497	CcSEcCtD
Eprosartan—Bone pain—Doxorubicin—muscle cancer	0.000823	0.00497	CcSEcCtD
Eprosartan—Back pain—Vincristine—muscle cancer	0.000794	0.00479	CcSEcCtD
Eprosartan—Myalgia—Dactinomycin—muscle cancer	0.000782	0.00472	CcSEcCtD
Eprosartan—Discomfort—Dactinomycin—muscle cancer	0.000773	0.00467	CcSEcCtD
Eprosartan—Cystitis noninfective—Doxorubicin—muscle cancer	0.000771	0.00465	CcSEcCtD
Eprosartan—Influenza like illness—Doxorubicin—muscle cancer	0.000766	0.00463	CcSEcCtD
Eprosartan—Cystitis—Doxorubicin—muscle cancer	0.000762	0.0046	CcSEcCtD
Eprosartan—Diabetes mellitus—Methotrexate—muscle cancer	0.00076	0.00459	CcSEcCtD
Eprosartan—Polyuria—Methotrexate—muscle cancer	0.000753	0.00455	CcSEcCtD
Eprosartan—Vertigo—Vincristine—muscle cancer	0.000737	0.00445	CcSEcCtD
Eprosartan—Thrombocytopenia—Dactinomycin—muscle cancer	0.000734	0.00443	CcSEcCtD
Eprosartan—Cramps of lower extremities—Doxorubicin—muscle cancer	0.000725	0.00438	CcSEcCtD
Eprosartan—Oesophagitis—Doxorubicin—muscle cancer	0.000721	0.00435	CcSEcCtD
Eprosartan—Rash maculo-papular—Doxorubicin—muscle cancer	0.000717	0.00433	CcSEcCtD
Eprosartan—Anorexia—Dactinomycin—muscle cancer	0.000715	0.00431	CcSEcCtD
Eprosartan—Bladder pain—Doxorubicin—muscle cancer	0.000713	0.00431	CcSEcCtD
Eprosartan—Myalgia—Vincristine—muscle cancer	0.000699	0.00422	CcSEcCtD
Eprosartan—Abnormal vision—Doxorubicin—muscle cancer	0.000688	0.00415	CcSEcCtD
Eprosartan—Chills—Etoposide—muscle cancer	0.000685	0.00414	CcSEcCtD
Eprosartan—Musculoskeletal discomfort—Dactinomycin—muscle cancer	0.000683	0.00412	CcSEcCtD
Eprosartan—Osteoarthritis—Methotrexate—muscle cancer	0.000661	0.00399	CcSEcCtD
Eprosartan—Diabetes mellitus—Doxorubicin—muscle cancer	0.000658	0.00397	CcSEcCtD
Eprosartan—Thrombocytopenia—Vincristine—muscle cancer	0.000656	0.00396	CcSEcCtD
Eprosartan—Decreased appetite—Dactinomycin—muscle cancer	0.000652	0.00393	CcSEcCtD
Eprosartan—Hyperhidrosis—Vincristine—muscle cancer	0.000648	0.00391	CcSEcCtD
Eprosartan—Fatigue—Dactinomycin—muscle cancer	0.000646	0.0039	CcSEcCtD
Eprosartan—Back pain—Etoposide—muscle cancer	0.000643	0.00388	CcSEcCtD
Eprosartan—Pain—Dactinomycin—muscle cancer	0.000641	0.00387	CcSEcCtD
Eprosartan—Vascular purpura—Doxorubicin—muscle cancer	0.00064	0.00386	CcSEcCtD
Eprosartan—Muscle spasms—Etoposide—muscle cancer	0.000639	0.00386	CcSEcCtD
Eprosartan—Anorexia—Vincristine—muscle cancer	0.000638	0.00386	CcSEcCtD
Eprosartan—Eczema—Doxorubicin—muscle cancer	0.000637	0.00385	CcSEcCtD
Eprosartan—Hypotension—Vincristine—muscle cancer	0.000626	0.00378	CcSEcCtD
Eprosartan—Ataxia—Methotrexate—muscle cancer	0.000622	0.00375	CcSEcCtD
Eprosartan—Feeling abnormal—Dactinomycin—muscle cancer	0.000618	0.00373	CcSEcCtD
Eprosartan—Ill-defined disorder—Etoposide—muscle cancer	0.000617	0.00372	CcSEcCtD
Eprosartan—Gastrointestinal pain—Dactinomycin—muscle cancer	0.000613	0.0037	CcSEcCtD
Eprosartan—Hot flush—Doxorubicin—muscle cancer	0.000612	0.0037	CcSEcCtD
Eprosartan—Musculoskeletal discomfort—Vincristine—muscle cancer	0.00061	0.00368	CcSEcCtD
Eprosartan—Menopausal symptoms—Doxorubicin—muscle cancer	0.000607	0.00366	CcSEcCtD
Eprosartan—Insomnia—Vincristine—muscle cancer	0.000606	0.00366	CcSEcCtD
Eprosartan—Paraesthesia—Vincristine—muscle cancer	0.000601	0.00363	CcSEcCtD
Eprosartan—Malaise—Etoposide—muscle cancer	0.0006	0.00362	CcSEcCtD
Eprosartan—Vertigo—Etoposide—muscle cancer	0.000597	0.00361	CcSEcCtD
Eprosartan—Purpura—Doxorubicin—muscle cancer	0.000594	0.00359	CcSEcCtD
Eprosartan—Abdominal pain—Dactinomycin—muscle cancer	0.000593	0.00358	CcSEcCtD
Eprosartan—Body temperature increased—Dactinomycin—muscle cancer	0.000593	0.00358	CcSEcCtD
Eprosartan—Cardiac failure—Doxorubicin—muscle cancer	0.000587	0.00354	CcSEcCtD
Eprosartan—Loss of consciousness—Etoposide—muscle cancer	0.000584	0.00353	CcSEcCtD
Eprosartan—Decreased appetite—Vincristine—muscle cancer	0.000582	0.00352	CcSEcCtD
Eprosartan—Cough—Etoposide—muscle cancer	0.00058	0.0035	CcSEcCtD
Eprosartan—Fatigue—Vincristine—muscle cancer	0.000577	0.00349	CcSEcCtD
Eprosartan—Hyponatraemia—Doxorubicin—muscle cancer	0.000575	0.00347	CcSEcCtD
Eprosartan—Constipation—Vincristine—muscle cancer	0.000573	0.00346	CcSEcCtD
Eprosartan—Pain—Vincristine—muscle cancer	0.000573	0.00346	CcSEcCtD
Eprosartan—Osteoarthritis—Doxorubicin—muscle cancer	0.000573	0.00346	CcSEcCtD
Eprosartan—Asthma—Methotrexate—muscle cancer	0.000572	0.00345	CcSEcCtD
Eprosartan—Chest pain—Etoposide—muscle cancer	0.000566	0.00342	CcSEcCtD
Eprosartan—Migraine—Doxorubicin—muscle cancer	0.000564	0.0034	CcSEcCtD
Eprosartan—Discomfort—Etoposide—muscle cancer	0.000559	0.00338	CcSEcCtD
Eprosartan—Face oedema—Doxorubicin—muscle cancer	0.000553	0.00334	CcSEcCtD
Eprosartan—Hypersensitivity—Dactinomycin—muscle cancer	0.000552	0.00334	CcSEcCtD
Eprosartan—Gastrointestinal pain—Vincristine—muscle cancer	0.000548	0.00331	CcSEcCtD
Eprosartan—Ataxia—Doxorubicin—muscle cancer	0.000538	0.00325	CcSEcCtD
Eprosartan—Asthenia—Dactinomycin—muscle cancer	0.000538	0.00325	CcSEcCtD
Eprosartan—Blood creatinine increased—Doxorubicin—muscle cancer	0.000536	0.00324	CcSEcCtD
Eprosartan—Thrombocytopenia—Etoposide—muscle cancer	0.000531	0.00321	CcSEcCtD
Eprosartan—Upper respiratory tract infection—Methotrexate—muscle cancer	0.000531	0.00321	CcSEcCtD
Eprosartan—Tachycardia—Etoposide—muscle cancer	0.00053	0.0032	CcSEcCtD
Eprosartan—Body temperature increased—Vincristine—muscle cancer	0.00053	0.0032	CcSEcCtD
Eprosartan—Abdominal pain—Vincristine—muscle cancer	0.00053	0.0032	CcSEcCtD
Eprosartan—Hyperhidrosis—Etoposide—muscle cancer	0.000525	0.00317	CcSEcCtD
Eprosartan—Orthostatic hypotension—Doxorubicin—muscle cancer	0.000523	0.00316	CcSEcCtD
Eprosartan—Hypokalaemia—Doxorubicin—muscle cancer	0.000521	0.00315	CcSEcCtD
Eprosartan—Anorexia—Etoposide—muscle cancer	0.000517	0.00312	CcSEcCtD
Eprosartan—Aspartate aminotransferase increased—Doxorubicin—muscle cancer	0.000516	0.00311	CcSEcCtD
Eprosartan—Diarrhoea—Dactinomycin—muscle cancer	0.000513	0.0031	CcSEcCtD
Eprosartan—Depression—Methotrexate—muscle cancer	0.000508	0.00307	CcSEcCtD
Eprosartan—Hypotension—Etoposide—muscle cancer	0.000507	0.00306	CcSEcCtD
Eprosartan—Gastritis—Doxorubicin—muscle cancer	0.000507	0.00306	CcSEcCtD
Eprosartan—Muscular weakness—Doxorubicin—muscle cancer	0.000505	0.00305	CcSEcCtD
Eprosartan—Alanine aminotransferase increased—Doxorubicin—muscle cancer	0.000505	0.00305	CcSEcCtD
Eprosartan—Renal failure—Methotrexate—muscle cancer	0.000501	0.00302	CcSEcCtD
Eprosartan—Conjunctivitis—Methotrexate—muscle cancer	0.000495	0.00299	CcSEcCtD
Eprosartan—Asthma—Doxorubicin—muscle cancer	0.000495	0.00299	CcSEcCtD
Eprosartan—Hypersensitivity—Vincristine—muscle cancer	0.000494	0.00298	CcSEcCtD
Eprosartan—Paraesthesia—Etoposide—muscle cancer	0.000487	0.00294	CcSEcCtD
Eprosartan—Haematuria—Methotrexate—muscle cancer	0.000486	0.00293	CcSEcCtD
Eprosartan—Dyspnoea—Etoposide—muscle cancer	0.000484	0.00292	CcSEcCtD
Eprosartan—Somnolence—Etoposide—muscle cancer	0.000482	0.00291	CcSEcCtD
Eprosartan—Angina pectoris—Doxorubicin—muscle cancer	0.000482	0.00291	CcSEcCtD
Eprosartan—Epistaxis—Methotrexate—muscle cancer	0.000481	0.0029	CcSEcCtD
Eprosartan—Asthenia—Vincristine—muscle cancer	0.000481	0.0029	CcSEcCtD
Eprosartan—Vomiting—Dactinomycin—muscle cancer	0.000477	0.00288	CcSEcCtD
Eprosartan—Bronchitis—Doxorubicin—muscle cancer	0.000476	0.00287	CcSEcCtD
Eprosartan—Rash—Dactinomycin—muscle cancer	0.000473	0.00285	CcSEcCtD
Eprosartan—Decreased appetite—Etoposide—muscle cancer	0.000472	0.00285	CcSEcCtD
Eprosartan—Fatigue—Etoposide—muscle cancer	0.000468	0.00282	CcSEcCtD
Eprosartan—Constipation—Etoposide—muscle cancer	0.000464	0.0028	CcSEcCtD
Eprosartan—Pain—Etoposide—muscle cancer	0.000464	0.0028	CcSEcCtD
Eprosartan—Upper respiratory tract infection—Doxorubicin—muscle cancer	0.00046	0.00278	CcSEcCtD
Eprosartan—Diarrhoea—Vincristine—muscle cancer	0.000458	0.00277	CcSEcCtD
Eprosartan—Pollakiuria—Doxorubicin—muscle cancer	0.000457	0.00276	CcSEcCtD
Eprosartan—Pharyngitis—Methotrexate—muscle cancer	0.000454	0.00274	CcSEcCtD
Eprosartan—Feeling abnormal—Etoposide—muscle cancer	0.000447	0.0027	CcSEcCtD
Eprosartan—Hyperglycaemia—Doxorubicin—muscle cancer	0.000446	0.0027	CcSEcCtD
Eprosartan—Nausea—Dactinomycin—muscle cancer	0.000445	0.00269	CcSEcCtD
Eprosartan—Gastrointestinal pain—Etoposide—muscle cancer	0.000444	0.00268	CcSEcCtD
Eprosartan—Dizziness—Vincristine—muscle cancer	0.000443	0.00267	CcSEcCtD
Eprosartan—Visual impairment—Methotrexate—muscle cancer	0.000441	0.00266	CcSEcCtD
Eprosartan—Renal failure—Doxorubicin—muscle cancer	0.000434	0.00262	CcSEcCtD
Eprosartan—Neuropathy peripheral—Doxorubicin—muscle cancer	0.000433	0.00261	CcSEcCtD
Eprosartan—Urticaria—Etoposide—muscle cancer	0.000431	0.0026	CcSEcCtD
Eprosartan—Abdominal pain—Etoposide—muscle cancer	0.000429	0.00259	CcSEcCtD
Eprosartan—Body temperature increased—Etoposide—muscle cancer	0.000429	0.00259	CcSEcCtD
Eprosartan—Conjunctivitis—Doxorubicin—muscle cancer	0.000429	0.00259	CcSEcCtD
Eprosartan—Urinary tract infection—Doxorubicin—muscle cancer	0.000429	0.00259	CcSEcCtD
Eprosartan—Tinnitus—Methotrexate—muscle cancer	0.000427	0.00258	CcSEcCtD
Eprosartan—Vomiting—Vincristine—muscle cancer	0.000426	0.00257	CcSEcCtD
Eprosartan—Rash—Vincristine—muscle cancer	0.000422	0.00255	CcSEcCtD
Eprosartan—Dermatitis—Vincristine—muscle cancer	0.000422	0.00255	CcSEcCtD
Eprosartan—Haematuria—Doxorubicin—muscle cancer	0.000421	0.00254	CcSEcCtD
Eprosartan—Headache—Vincristine—muscle cancer	0.00042	0.00253	CcSEcCtD
Eprosartan—Epistaxis—Doxorubicin—muscle cancer	0.000416	0.00251	CcSEcCtD
Eprosartan—Sinusitis—Doxorubicin—muscle cancer	0.000414	0.0025	CcSEcCtD
Eprosartan—Chills—Methotrexate—muscle cancer	0.00041	0.00248	CcSEcCtD
Eprosartan—Bradycardia—Doxorubicin—muscle cancer	0.000403	0.00243	CcSEcCtD
Eprosartan—Hypersensitivity—Etoposide—muscle cancer	0.0004	0.00241	CcSEcCtD
Eprosartan—Nausea—Vincristine—muscle cancer	0.000398	0.0024	CcSEcCtD
Eprosartan—Rhinitis—Doxorubicin—muscle cancer	0.000397	0.0024	CcSEcCtD
Eprosartan—Pharyngitis—Doxorubicin—muscle cancer	0.000393	0.00237	CcSEcCtD
Eprosartan—Oedema peripheral—Doxorubicin—muscle cancer	0.00039	0.00236	CcSEcCtD
Eprosartan—Asthenia—Etoposide—muscle cancer	0.000389	0.00235	CcSEcCtD
Eprosartan—Back pain—Methotrexate—muscle cancer	0.000385	0.00233	CcSEcCtD
Eprosartan—Pruritus—Etoposide—muscle cancer	0.000384	0.00232	CcSEcCtD
Eprosartan—Visual impairment—Doxorubicin—muscle cancer	0.000382	0.0023	CcSEcCtD
Eprosartan—Diarrhoea—Etoposide—muscle cancer	0.000371	0.00224	CcSEcCtD
Eprosartan—Ill-defined disorder—Methotrexate—muscle cancer	0.000369	0.00223	CcSEcCtD
Eprosartan—Tinnitus—Doxorubicin—muscle cancer	0.000369	0.00223	CcSEcCtD
Eprosartan—Malaise—Methotrexate—muscle cancer	0.000359	0.00217	CcSEcCtD
Eprosartan—Dizziness—Etoposide—muscle cancer	0.000359	0.00217	CcSEcCtD
Eprosartan—Vertigo—Methotrexate—muscle cancer	0.000358	0.00216	CcSEcCtD
Eprosartan—Chills—Doxorubicin—muscle cancer	0.000355	0.00215	CcSEcCtD
Eprosartan—Cough—Methotrexate—muscle cancer	0.000348	0.0021	CcSEcCtD
Eprosartan—Vomiting—Etoposide—muscle cancer	0.000345	0.00208	CcSEcCtD
Eprosartan—Rash—Etoposide—muscle cancer	0.000342	0.00207	CcSEcCtD
Eprosartan—Dermatitis—Etoposide—muscle cancer	0.000342	0.00206	CcSEcCtD
Eprosartan—Headache—Etoposide—muscle cancer	0.00034	0.00205	CcSEcCtD
Eprosartan—Flatulence—Doxorubicin—muscle cancer	0.00034	0.00205	CcSEcCtD
Eprosartan—Arthralgia—Methotrexate—muscle cancer	0.000339	0.00205	CcSEcCtD
Eprosartan—Chest pain—Methotrexate—muscle cancer	0.000339	0.00205	CcSEcCtD
Eprosartan—Myalgia—Methotrexate—muscle cancer	0.000339	0.00205	CcSEcCtD
Eprosartan—Tension—Doxorubicin—muscle cancer	0.000338	0.00204	CcSEcCtD
Eprosartan—Discomfort—Methotrexate—muscle cancer	0.000335	0.00202	CcSEcCtD
Eprosartan—Nervousness—Doxorubicin—muscle cancer	0.000335	0.00202	CcSEcCtD
Eprosartan—Back pain—Doxorubicin—muscle cancer	0.000334	0.00201	CcSEcCtD
Eprosartan—Muscle spasms—Doxorubicin—muscle cancer	0.000332	0.002	CcSEcCtD
Eprosartan—Nausea—Etoposide—muscle cancer	0.000322	0.00195	CcSEcCtD
Eprosartan—Ill-defined disorder—Doxorubicin—muscle cancer	0.00032	0.00193	CcSEcCtD
Eprosartan—Thrombocytopenia—Methotrexate—muscle cancer	0.000318	0.00192	CcSEcCtD
Eprosartan—Hyperhidrosis—Methotrexate—muscle cancer	0.000314	0.0019	CcSEcCtD
Eprosartan—Malaise—Doxorubicin—muscle cancer	0.000311	0.00188	CcSEcCtD
Eprosartan—Vertigo—Doxorubicin—muscle cancer	0.00031	0.00187	CcSEcCtD
Eprosartan—Anorexia—Methotrexate—muscle cancer	0.00031	0.00187	CcSEcCtD
Eprosartan—Syncope—Doxorubicin—muscle cancer	0.000309	0.00187	CcSEcCtD
Eprosartan—Palpitations—Doxorubicin—muscle cancer	0.000305	0.00184	CcSEcCtD
Eprosartan—Hypotension—Methotrexate—muscle cancer	0.000304	0.00183	CcSEcCtD
Eprosartan—Loss of consciousness—Doxorubicin—muscle cancer	0.000303	0.00183	CcSEcCtD
Eprosartan—Cough—Doxorubicin—muscle cancer	0.000301	0.00182	CcSEcCtD
Eprosartan—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.000296	0.00179	CcSEcCtD
Eprosartan—Insomnia—Methotrexate—muscle cancer	0.000294	0.00177	CcSEcCtD
Eprosartan—Arthralgia—Doxorubicin—muscle cancer	0.000294	0.00177	CcSEcCtD
Eprosartan—Chest pain—Doxorubicin—muscle cancer	0.000294	0.00177	CcSEcCtD
Eprosartan—Myalgia—Doxorubicin—muscle cancer	0.000294	0.00177	CcSEcCtD
Eprosartan—Anxiety—Doxorubicin—muscle cancer	0.000293	0.00177	CcSEcCtD
Eprosartan—Paraesthesia—Methotrexate—muscle cancer	0.000292	0.00176	CcSEcCtD
Eprosartan—Discomfort—Doxorubicin—muscle cancer	0.00029	0.00175	CcSEcCtD
Eprosartan—Dyspnoea—Methotrexate—muscle cancer	0.00029	0.00175	CcSEcCtD
Eprosartan—Somnolence—Methotrexate—muscle cancer	0.000289	0.00174	CcSEcCtD
Eprosartan—Dry mouth—Doxorubicin—muscle cancer	0.000287	0.00173	CcSEcCtD
Eprosartan—Dyspepsia—Methotrexate—muscle cancer	0.000286	0.00173	CcSEcCtD
Eprosartan—Decreased appetite—Methotrexate—muscle cancer	0.000283	0.00171	CcSEcCtD
Eprosartan—Fatigue—Methotrexate—muscle cancer	0.00028	0.00169	CcSEcCtD
Eprosartan—Pain—Methotrexate—muscle cancer	0.000278	0.00168	CcSEcCtD
Eprosartan—Shock—Doxorubicin—muscle cancer	0.000277	0.00167	CcSEcCtD
Eprosartan—Thrombocytopenia—Doxorubicin—muscle cancer	0.000276	0.00166	CcSEcCtD
Eprosartan—Tachycardia—Doxorubicin—muscle cancer	0.000275	0.00166	CcSEcCtD
Eprosartan—Hyperhidrosis—Doxorubicin—muscle cancer	0.000272	0.00164	CcSEcCtD
Eprosartan—Anorexia—Doxorubicin—muscle cancer	0.000268	0.00162	CcSEcCtD
Eprosartan—Feeling abnormal—Methotrexate—muscle cancer	0.000268	0.00162	CcSEcCtD
Eprosartan—Gastrointestinal pain—Methotrexate—muscle cancer	0.000266	0.0016	CcSEcCtD
Eprosartan—Hypotension—Doxorubicin—muscle cancer	0.000263	0.00159	CcSEcCtD
Eprosartan—Urticaria—Methotrexate—muscle cancer	0.000258	0.00156	CcSEcCtD
Eprosartan—Abdominal pain—Methotrexate—muscle cancer	0.000257	0.00155	CcSEcCtD
Eprosartan—Body temperature increased—Methotrexate—muscle cancer	0.000257	0.00155	CcSEcCtD
Eprosartan—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.000256	0.00155	CcSEcCtD
Eprosartan—Insomnia—Doxorubicin—muscle cancer	0.000255	0.00154	CcSEcCtD
Eprosartan—Paraesthesia—Doxorubicin—muscle cancer	0.000253	0.00153	CcSEcCtD
Eprosartan—Dyspnoea—Doxorubicin—muscle cancer	0.000251	0.00151	CcSEcCtD
Eprosartan—Somnolence—Doxorubicin—muscle cancer	0.00025	0.00151	CcSEcCtD
Eprosartan—Dyspepsia—Doxorubicin—muscle cancer	0.000248	0.0015	CcSEcCtD
Eprosartan—Decreased appetite—Doxorubicin—muscle cancer	0.000245	0.00148	CcSEcCtD
Eprosartan—Fatigue—Doxorubicin—muscle cancer	0.000243	0.00146	CcSEcCtD
Eprosartan—Pain—Doxorubicin—muscle cancer	0.000241	0.00145	CcSEcCtD
Eprosartan—Constipation—Doxorubicin—muscle cancer	0.000241	0.00145	CcSEcCtD
Eprosartan—Hypersensitivity—Methotrexate—muscle cancer	0.000239	0.00145	CcSEcCtD
Eprosartan—Asthenia—Methotrexate—muscle cancer	0.000233	0.00141	CcSEcCtD
Eprosartan—Feeling abnormal—Doxorubicin—muscle cancer	0.000232	0.0014	CcSEcCtD
Eprosartan—Gastrointestinal pain—Doxorubicin—muscle cancer	0.00023	0.00139	CcSEcCtD
Eprosartan—Pruritus—Methotrexate—muscle cancer	0.00023	0.00139	CcSEcCtD
Eprosartan—Urticaria—Doxorubicin—muscle cancer	0.000224	0.00135	CcSEcCtD
Eprosartan—Abdominal pain—Doxorubicin—muscle cancer	0.000222	0.00134	CcSEcCtD
Eprosartan—Body temperature increased—Doxorubicin—muscle cancer	0.000222	0.00134	CcSEcCtD
Eprosartan—Diarrhoea—Methotrexate—muscle cancer	0.000222	0.00134	CcSEcCtD
Eprosartan—Dizziness—Methotrexate—muscle cancer	0.000215	0.0013	CcSEcCtD
Eprosartan—Hypersensitivity—Doxorubicin—muscle cancer	0.000207	0.00125	CcSEcCtD
Eprosartan—Vomiting—Methotrexate—muscle cancer	0.000207	0.00125	CcSEcCtD
Eprosartan—Rash—Methotrexate—muscle cancer	0.000205	0.00124	CcSEcCtD
Eprosartan—Dermatitis—Methotrexate—muscle cancer	0.000205	0.00124	CcSEcCtD
Eprosartan—Headache—Methotrexate—muscle cancer	0.000204	0.00123	CcSEcCtD
Eprosartan—Asthenia—Doxorubicin—muscle cancer	0.000202	0.00122	CcSEcCtD
Eprosartan—Pruritus—Doxorubicin—muscle cancer	0.000199	0.0012	CcSEcCtD
Eprosartan—Nausea—Methotrexate—muscle cancer	0.000193	0.00117	CcSEcCtD
Eprosartan—Diarrhoea—Doxorubicin—muscle cancer	0.000193	0.00116	CcSEcCtD
Eprosartan—Dizziness—Doxorubicin—muscle cancer	0.000186	0.00112	CcSEcCtD
Eprosartan—Vomiting—Doxorubicin—muscle cancer	0.000179	0.00108	CcSEcCtD
Eprosartan—Rash—Doxorubicin—muscle cancer	0.000177	0.00107	CcSEcCtD
Eprosartan—Dermatitis—Doxorubicin—muscle cancer	0.000177	0.00107	CcSEcCtD
Eprosartan—Headache—Doxorubicin—muscle cancer	0.000176	0.00106	CcSEcCtD
Eprosartan—Nausea—Doxorubicin—muscle cancer	0.000167	0.00101	CcSEcCtD
